Orange Book product · Brand (NDA)
DANZITEN
NILOTINIB TARTRATE
At a glance
Nov 07, 2024
Approved
Brand (NDA)
Application
Not listed
TE code
4
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 07, 2024
1 yr 8 mo ago
Today
Patent 10874671 expires
Listed drug product patent expiration.
Feb 18, 2040
in 13 yr 10 mo
Patent 11793809 expires
Listed drug product patent expiration.
Feb 18, 2040
in 13 yr 10 mo
Patent 12403140 expires
Listed drug product patent expiration.
Feb 18, 2040
in 13 yr 10 mo
Patent 12629369 expires
Listed drug product patent expiration.
Feb 18, 2040
in 13 yr 10 mo
Pharmaceutical detail
Active ingredient
NILOTINIB TARTRATE
Strength
EQ 71MG BASE
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 219293
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (4)
| Patent | Expires | In | Type |
|---|---|---|---|
| 10874671 | Feb 18, 2040 | in 13 yr 10 mo | Product |
| 11793809 | Feb 18, 2040 | in 13 yr 10 mo | Product |
| 12403140 | Feb 18, 2040 | in 13 yr 10 mo | Product |
| 12629369 | Feb 18, 2040 | in 13 yr 10 mo | Product |
